Foe to Ally: Oncolytic Virus‐Driven Xenorejection Ignites Potent Antitumor Immunity

Foe to Ally: Oncolytic Virus‐Driven Xenorejection Ignites Potent Antitumor Immunity

Saved in:

Bibliographic Details
Main Authors:	Yanglin Xu, Bingcheng Chang, Wei He, Jia Liu
Format:	Article
Language:	English
Published:	Wiley 2025-06-01
Series:	MedComm – Oncology
Online Access:	https://doi.org/10.1002/mog2.70025
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Role of Nitric Oxide in Cancer Treatment: Ally or Foe?
by: Angelika Myśliwiec, et al.
Published: (2025-06-01)

Oncolytic Vaccinia Virus Armed with GM-CSF and IL-7 Enhances Antitumor Immunity in Pancreatic Cancer
by: Wenyi Yan, et al.
Published: (2025-04-01)

A recombinant oncolytic Newcastle virus expressing MIP-3α promotes systemic antitumor immunity
by: Yan Sun, et al.
Published: (2020-10-01)

Oncolytic herpes simplex virus reprograms cancer-associated fibroblasts to enhance antitumor immunity in pancreatic cancer
by: Feilong Zhou, et al.
Published: (2025-09-01)

Initial dose of oncolytic myxoma virus programs durable antitumor immunity independent of in vivo viral replication
by: Eric Bartee, et al.
Published: (2020-05-01)

Mitochondrial metabolic reprogramming of macrophages and T cells enhances CD47 antibody-engineered oncolytic virus antitumor immunity
by: Ping Cheng, et al.
Published: (2024-12-01)

Durable antitumor response via an oncolytic virus encoding decoy-resistant IL-18
by: Yu Liu, et al.
Published: (2024-12-01)

Engineered oncolytic virus OH2-FLT3L enhances antitumor immunity via dendritic cell activation
by: Duo Wan, et al.
Published: (2025-06-01)

Engineered oncolytic virus OH2-FLT3L enhances antitumor immunity via dendritic cell activation
by: Duo Wan, et al.
Published: (2025-06-01)

Trabectedin promotes oncolytic virus antitumor efficacy, viral gene expression, and immune effector function in models of bone sarcoma
by: Emily M. Ringwalt, et al.
Published: (2024-12-01)

Host Immune Response to Dengue Virus Infection: Friend or Foe?
by: Priya Dhole, et al.
Published: (2024-11-01)

Oncolytic virus-mediated p53 activation boosts the antitumor immunity of a p53-transduced dendritic cell vaccine
by: Motohiko Yamada, et al.
Published: (2025-07-01)

Engineered oncolytic virus expressing B7H3-targeting BiTE enhances antitumor T-cell immune response
by: Ying Liu, et al.
Published: (2024-11-01)

Oncolytic vaccinia virus delivering tethered IL-12 enhances antitumor effects with improved safety
by: David L Bartlett, et al.
Published: (2020-05-01)

circ-1584 selectively promotes the antitumor activity of the oncolytic virus M1 on pancreatic cancer
by: Taofang Hao, et al.
Published: (2025-03-01)

Eliciting an immune-mediated antitumor response through oncolytic herpes simplex virus-based shared antigen expression in tumors resistant to viroimmunotherapy
by: Chun-Yu Chen, et al.
Published: (2021-10-01)

Oncolytic Viruses
by: Nanhai G. Chen, et al.
Published: (2012-01-01)

The impact of innate immune response on the efficacy of oncolytic viruses
by: Kirill N. Trachuk, et al.
Published: (2024-12-01)

Expression of SIRPα-Fc by oncolytic virus enhances antitumor efficacy through tumor microenvironment reprogramming
by: Qingzhe Yang, et al.
Published: (2025-02-01)

Oncolytic vaccinia virus harboring CLEC2A gene enhances viral replication and antitumor efficacy
by: Chunqing Gao, et al.
Published: (2024-09-01)

A novel oncolytic Vaccinia virus armed with IL-12 augments antitumor immune responses leading to durable regression in murine models of lung cancer
by: Lijuan Chen, et al.
Published: (2025-01-01)

Oncolytic adenovirus serotype 35 mediated tumor growth suppression via efficient activation of antitumor immunity
by: Ken J Ishii, et al.
Published: (2025-07-01)

4-1BBL-Armed Oncolytic Herpes Simplex Virus Exerts Antitumor Effects in Pancreatic Ductal Adenocarcinoma
by: Wenrui Gao, et al.
Published: (2024-11-01)

Unveiling the nexus: Oncolytic viruses, extracellular vesicles, and immune modulation
by: Pierre Cordelier
Published: (2025-03-01)

CD47 antibody-armed oncolytic adenovirus promotes chimeric antigen receptor macrophage phagocytosis and antitumor immunity
by: Zhongbing Qi, et al.
Published: (2025-08-01)

Antitumor power of oncolytic HSV engineered with IL-12 and IL-15
by: Lei Zhang, et al.
Published: (2025-09-01)

Construction of chimeric IL-21 recombinant oncolytic influenza virus and mechanisms for its antitumor efficacy against hepatocellular carcinoma
by: CAO Rui, et al.
Published: (2024-12-01)

The 16th International Oncolytic Virus Conference: Advancing oncolytic virotherapy by balancing anti-tumor and anti-viral immunity
by: Eftychia Stavrakaki, et al.
Published: (2025-03-01)

Oncolytic virotherapy provides a potent therapy option for squamous bladder cancer
by: Julia Pannhausen, et al.
Published: (2025-04-01)

Targeting site-specific N-glycosylated B7H3 induces potent antitumor immunity
by: Yun Huang, et al.
Published: (2025-04-01)

Clinical trials on oncolytic viruses
by: I. V. Golovinov, et al.
Published: (2025-01-01)

Translation of oncolytic viruses in sarcoma
by: Steven I. Robinson, et al.
Published: (2024-09-01)

An oncolytic vaccinia virus expressing anti-CD47 nanobody exerts enhanced antitumor activity by mediating innate and adaptive immune cell infiltration and activation in the lymphoma tumor microenvironment
by: Mengyuan Li, et al.
Published: (2025-04-01)

From Defoe to Coetzee’s Foe/Foe through Authorship
by: Andreia Irina Suciu, et al.
Published: (2021-07-01)

Retargeting of Viruses to Generate Oncolytic Agents
by: M. H. Verheije, et al.
Published: (2012-01-01)

Oncolytic Viruses in the Treatment of Bladder Cancer
by: Kyle G. Potts, et al.
Published: (2012-01-01)

Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivity
by: Akseli Hemminki, et al.
Published: (2020-05-01)

Research progress and development potential of oncolytic vaccinia virus
by: Xinyu Zhang, et al.
Published: (2025-04-01)

Friend or foe?
by: Louis J. Kotzé, et al.
Published: (2021-02-01)

Oncolytic Virus-Based Immunotherapies for Hepatocellular Carcinoma
by: So Young Yoo, et al.
Published: (2017-01-01)